sulthiame has been researched along with Seizures in 8 studies
sulthiame: was heading 1964-94 (see under THIAZINES 1964-90); use THIAZINES to search SULTHIAME 1966-94
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulthiame may have a role in the early treatment of seizures in children with refractory epilepsy due to FRRS1L mutation." | 8.12 | Clonic seizures, continuous spikes-and-waves during slow sleep, choreoathetosis and response to sulthiame in a child with FRRS1L encephalopathy. ( Hadi, DA; Khoo, TB; Mohamed, AR; Rethanavelu, K, 2022) |
| "Sulthiame was found to be effective in seizure control and EEG improvement in ESES." | 5.62 | Effects of sulthiame on seizure frequency and EEG in children with electrical status epilepticus during slow sleep. ( Aydın, K; Kılıç, B; Tekin, HG; Topçu, Y; Turanlı, G, 2021) |
| "Sulthiame may have a role in the early treatment of seizures in children with refractory epilepsy due to FRRS1L mutation." | 4.12 | Clonic seizures, continuous spikes-and-waves during slow sleep, choreoathetosis and response to sulthiame in a child with FRRS1L encephalopathy. ( Hadi, DA; Khoo, TB; Mohamed, AR; Rethanavelu, K, 2022) |
| "Epileptic seizures are often not the main problem in atypical rolandic epilepsies like CSWS or LKS and the amelioration of cognitive dysfunction by epileptic discharge is the prominent aim of an AED therapy." | 2.41 | Treatment in typical and atypical rolandic epilepsy. ( Rating, D, 2000) |
| "Sulthiame was added in doses ranging from 10 to 40 mg/kg/day." | 1.91 | Use of sulthiame as add-on therapy in children with non-self-limited focal epilepsies of childhood. ( Adi, J; Cachia, P; Caraballo, R; Chacón, S; Espeche, A; Fortini, S; Galichio, S; Gallo, A; Gamboni, B; Reyes, G; Semprino, M, 2023) |
| "Sulthiame was added in doses ranging from 10 to 30 mg/kg/day." | 1.72 | Use of sulthiame as add-on therapy in children with myoclonic atonic epilepsy: A study of 35 patients. ( Bautista, C; Cachia, P; Caraballo, RH; Espeche, A; Fortini, S; Galicchio, S; Gallo, A; Gamboni, B; Reyes Valenzuela, G; Semprino, M, 2022) |
| "Sulthiame was found to be effective in seizure control and EEG improvement in ESES." | 1.62 | Effects of sulthiame on seizure frequency and EEG in children with electrical status epilepticus during slow sleep. ( Aydın, K; Kılıç, B; Tekin, HG; Topçu, Y; Turanlı, G, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadi, DA | 1 |
| Mohamed, AR | 1 |
| Rethanavelu, K | 1 |
| Khoo, TB | 1 |
| Caraballo, RH | 1 |
| Reyes Valenzuela, G | 1 |
| Fortini, S | 2 |
| Espeche, A | 2 |
| Gamboni, B | 2 |
| Bautista, C | 1 |
| Cachia, P | 2 |
| Semprino, M | 2 |
| Gallo, A | 2 |
| Galicchio, S | 1 |
| Caraballo, R | 1 |
| Reyes, G | 1 |
| Chacón, S | 1 |
| Galichio, S | 1 |
| Adi, J | 1 |
| Topçu, Y | 1 |
| Kılıç, B | 1 |
| Tekin, HG | 1 |
| Aydın, K | 1 |
| Turanlı, G | 1 |
| DOOSE, H | 1 |
| KLUGE, D | 1 |
| EHMSEN, U | 1 |
| GORDON, N | 1 |
| Song, HK | 1 |
| Hamada, K | 1 |
| Yagi, K | 1 |
| Seino, M | 1 |
| Rating, D | 1 |
1 review available for sulthiame and Seizures
| Article | Year |
|---|---|
Treatment in typical and atypical rolandic epilepsy.
Topics: Adolescent; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Child; Contraindications; Dose-Re | 2000 |
7 other studies available for sulthiame and Seizures
| Article | Year |
|---|---|
Clonic seizures, continuous spikes-and-waves during slow sleep, choreoathetosis and response to sulthiame in a child with FRRS1L encephalopathy.
Topics: Anticonvulsants; Drug Resistant Epilepsy; Humans; Infant; Male; Membrane Proteins; Nerve Tissue Prot | 2022 |
Use of sulthiame as add-on therapy in children with myoclonic atonic epilepsy: A study of 35 patients.
Topics: Anticonvulsants; Child; Drug-Related Side Effects and Adverse Reactions; Epilepsy, Generalized; Huma | 2022 |
Use of sulthiame as add-on therapy in children with non-self-limited focal epilepsies of childhood.
Topics: Adolescent; Anticonvulsants; Child; Drug Therapy, Combination; Epilepsies, Partial; Humans; Retrospe | 2023 |
Effects of sulthiame on seizure frequency and EEG in children with electrical status epilepticus during slow sleep.
Topics: Anticonvulsants; Child; Child, Preschool; Electroencephalography; Follow-Up Studies; Humans; Retrosp | 2021 |
[EXPERIENCES WITH OSPOLOT IN THE TREATMENT OF INFANTILE EPILEPSY].
Topics: Anticonvulsants; Child; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic | 1964 |
SULTHIAME (OSPOLOT) IN THE TREATMENT OF EPILEPSY.
Topics: Anticonvulsants; Child; Child Behavior Disorders; Epilepsy; Epilepsy, Temporal Lobe; Epilepsy, Tonic | 1964 |
Effects of single and repeated administration of sulthiame on amygdaloid kindled seizures in rats.
Topics: Amygdala; Animals; Anticonvulsants; Electroencephalography; Kindling, Neurologic; Male; Myoclonus; R | 1997 |